Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-dependent anion channel 1 (VDAC1) is a major mitochondrial outer membrane protein that facilitates the transport of ions and metabolites across the membrane. It plays a critical role in cellular energy metabolism, apoptosis, and calcium signaling. Dysregulation of VDAC1 is implicated in various diseases, including cancer, neurodegenerative disorders, and diabetes, making it a potential therapeutic target.
Channel modulation; Inhibition of protein-protein interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent anion channel 1 (VDAC1).